Randomized Study of Oral Aesculus Hippocastanum and Combinations in Hemorrhoidal Disease After 60 Days of Treatment

Inclusion Criteria: * Grade 1, 2 or 3 hemorrhoidal disease * Complaints related to haemorrhoidal disease/acute hemorrhoidal crisis (defined as acute anal pain due to haemorrhoidal prolapse with or without bleeding, edema and thrombosis) * For female patients of reproductive age, not pregnant or breastfeeding, using reliable contraception. * Patient has read, understood, signed and dated the informed consent form Exclusion Criteria: * Presence of concomitant severe systemic disorders * Treatment with venotonics within 2 months of the date of inclusion in the study * Women of reproductive age who are pregnant or breastfeeding, or who do not wish to use contraception during the study period. * Known allergy or hypersensitivity to any component of the study medication * Known significant laboratory abnormality * Anal fissure * Inflammatory bowel disease * Colorectal cancer * Anal abscess or fistula * Previous anorectal surgery and/or radiotherapy in the pelvic-perineal region * Patient with a change in general condition that is incompatible with her participation in the study * Patient who wishes to become pregnant within 6 months * Inability of the patient to understand the nature of the study and follow the doctor's recommendations